reference/12796319

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12796319

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	40
issn	0920-1211
pageRange	34-40
publicationName	Epilepsy Research
startingPage	34
bibliographicCitation	Glauser T, Laurenza A, Yang H, Williams B, Ma T, Fain R. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis. Epilepsy Res. 2016 Jan;119():34–40. doi: 10.1016/j.eplepsyres.2015.11.014. PMID: 26656783.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86795c5a842dbc68d5989875d474378b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e9ad8ef71a3b3dbeb76f3a7d8575112 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4a2a72543bd7de12c63202bc80f82c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_010f3206719c749366be02ad578defbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9739-6598 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_834dd6d9f995e64bf226497b4106db0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eefece1f92fa1ed4789c6c829d0e3f00
date	201601
identifier	https://pubmed.ncbi.nlm.nih.gov/26656783 https://doi.org/10.1016/j.eplepsyres.2015.11.014
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 https://portal.issn.org/resource/ISSN/0920-1211
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis
discusses	http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0018236 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0549034
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011728Q000008 http://id.nlm.nih.gov/mesh/D000927Q000008 http://id.nlm.nih.gov/mesh/D004827Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D012640Q000188 http://id.nlm.nih.gov/mesh/D011728Q000009 http://id.nlm.nih.gov/mesh/D000927Q000009 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016015 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D009570 http://id.nlm.nih.gov/mesh/D057285 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9924495 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1221

Total number of triples: 50.